Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: AbbVie
Condition: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
NCT05041257
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.